Necitumumab Intravenous and Thromboembolic disorders
Result of checking the interaction of drug Necitumumab Intravenous and disease Thromboembolic disorders for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Venous and arterial thromboembolic events (VTE and ATE), some fatal, were observed with necitumumab in combination with gemcitabine and cisplatin. Caution is recommended when using necitumumab in patients with a reported history of VTE or ATE. Necitumumab should be discontinued in patients with serious or life threatening VTE or ATE.
Generic Name: necitumumab
Brand Name: Portrazza
Synonyms: Necitumumab